Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseSabatine MS, FOURIER Steering Committee and Investigators. -
Mortality Differences Associated With Treatment Responses in CANTOS and FOURIER: Insights and ImplicationsRidker PM
-
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES TrialM Szarek, HD White, PH Steg, ODYSSEY OUTCOMES Committees and Investigators.
-
Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary InterventionDanek BA, Karatasakis A, Brilakis ES et al.
-
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failurePonikowski P, Voors AA, ESC Scientific Document Group. et al.
-
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trialRV Jeger, A Farrah, MA Ohlow et al.
-
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialRidker PM, MacFadyen JG, CANTOS Trial Group et al.
-
Chronic Total Occlusion Percutaneous Coronary Intervention: Evidence and ControversiesTajti P, Brilakis ES.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
